These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

878 related items for PubMed ID: 18232012

  • 1. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [Abstract] [Full Text] [Related]

  • 2. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
    Brück W, Popescu B, Lucchinetti CF, Markovic-Plese S, Gold R, Thal DR, Metz I.
    Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
    [Abstract] [Full Text] [Related]

  • 3. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
    Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H.
    Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
    [Abstract] [Full Text] [Related]

  • 4. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP, Barnett MH, Parratt JD, Prineas JW.
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [Abstract] [Full Text] [Related]

  • 5. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y.
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [Abstract] [Full Text] [Related]

  • 6. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].
    Komoly S.
    Ideggyogy Sz; 2005 Jan 20; 58(1-2):40-3. PubMed ID: 15884397
    [Abstract] [Full Text] [Related]

  • 7. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W.
    Glia; 1999 Oct 20; 28(1):34-9. PubMed ID: 10498820
    [Abstract] [Full Text] [Related]

  • 8. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.
    Brain; 2007 May 20; 130(Pt 5):1194-205. PubMed ID: 17282996
    [Abstract] [Full Text] [Related]

  • 9. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.
    Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, Probert L.
    Am J Pathol; 1998 Sep 20; 153(3):801-13. PubMed ID: 9736029
    [Abstract] [Full Text] [Related]

  • 10. Multiple sclerosis: lessons from neuropathology.
    Lucchinetti CF, Brueck W, Rodriguez M, Lassmann H.
    Semin Neurol; 1998 Sep 20; 18(3):337-49. PubMed ID: 9817538
    [Abstract] [Full Text] [Related]

  • 11. Multiple sclerosis: classification revisited reveals homogeneity and recapitulation.
    Raine CS.
    Ann Neurol; 2008 Jan 20; 63(1):1-3. PubMed ID: 18232014
    [No Abstract] [Full Text] [Related]

  • 12. Remyelination capacity of the MS brain decreases with disease chronicity.
    Goldschmidt T, Antel J, König FB, Brück W, Kuhlmann T.
    Neurology; 2009 Jun 02; 72(22):1914-21. PubMed ID: 19487649
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N, Bö L, Hoek RM, Huitinga I.
    Ann Neurol; 2007 Nov 02; 62(5):504-14. PubMed ID: 17879969
    [Abstract] [Full Text] [Related]

  • 14. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
    Falcone M, Scalise A, Minisci C, Romito D, Cancelli I, Gigli GL.
    Neurol Sci; 2006 Apr 02; 27(1):58-62. PubMed ID: 16688601
    [Abstract] [Full Text] [Related]

  • 15. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG, Moscarello MA.
    J Neurosci Res; 2005 May 01; 80(3):301-8. PubMed ID: 15704220
    [Abstract] [Full Text] [Related]

  • 16. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.
    Gendelman HE, Pezeshkpour GH, Pressman NJ, Wolinsky JS, Quarles RH, Dobersen MJ, Trapp BD, Kitt CA, Aksamit A, Johnson RT.
    Ann Neurol; 1985 Sep 01; 18(3):324-8. PubMed ID: 2413798
    [Abstract] [Full Text] [Related]

  • 17. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
    Rus H, Cudrici C, Niculescu F, Shin ML.
    J Neuroimmunol; 2006 Nov 01; 180(1-2):9-16. PubMed ID: 16905199
    [Abstract] [Full Text] [Related]

  • 18. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H.
    Med Hypotheses; 2010 Aug 01; 75(2):229-34. PubMed ID: 20227191
    [Abstract] [Full Text] [Related]

  • 19. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W, Schmied M, Suchanek G, Brück Y, Breitschopf H, Poser S, Piddlesden S, Lassmann H.
    Ann Neurol; 1994 Jan 01; 35(1):65-73. PubMed ID: 8285595
    [Abstract] [Full Text] [Related]

  • 20. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
    Vos CM, Geurts JJ, Montagne L, van Haastert ES, Bö L, van der Valk P, Barkhof F, de Vries HE.
    Neurobiol Dis; 2005 Dec 01; 20(3):953-60. PubMed ID: 16039866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.